Vaxcyte (PCVX) had the highest return between September 1, 2022 and October 31, 2022 by a large-cap US stock, returning 67%.
Vaxcyte (PCVX) had the highest return between September 1, 2022 and October 31, 2022 by a large-cap US stock, returning 67%.
Large-cap stocks are treated as having a market cap of $10B+.